Pre-revenue development-stage profile and lower quarterly loss
QuantumScape reported no revenue to date and a Q2 FY2026 operating loss of $106.1M, compared with a $123.6M operating loss in the prior-year quarter. The company reported an accumulated deficit of approximately $4.0B through June 30, 2026 and expects significant expenses and continuing losses for the foreseeable future. Source: 10-Q Item 2 MD&A, p.21; 10-Q Item 2 MD&A, p.25
R&D expense declined, primarily from lower impairment and depreciation
Research and development expense fell 18% year over year to $82.5M in Q2 FY2026. Management attributed the $18.6M decrease primarily to $13.6M less impairment loss, $5.6M less depreciation and amortization, and $2.1M lower facility costs, partly offset by $1.3M higher materials costs and $0.9M more non-cash stock-based compensation. Source: 10-Q Item 2 MD&A, p.25
San Jose pilot line has entered its initial ramp-up phase
The company installed its highly automated battery-cell pilot production line in San Jose during 2025 and inaugurated it in February 2026, beginning initial capacity ramp-up. Management expects the line, once ramped, to support internal development, customer sampling, initial QSE-5 production, process development, and technology-transfer work with PowerCo. Source: 10-Q Item 2 MD&A, p.22